Pages that link to "Q46558961"
Jump to navigation
Jump to search
The following pages link to Virological Response and Resistance Profiles After 18 to 30 Months of First- or Second-/Third-Line Antiretroviral Treatment: A Cross-Sectional Evaluation in HIV Type 1-Infected Children Living in the Central African Republic (Q46558961):
Displaying 22 items.
- Sequencing paediatric antiretroviral therapy in the context of a public health approach (Q26774261) (← links)
- High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain (Q28484394) (← links)
- Getting to 90-90-90 in paediatric HIV: What is needed? (Q30385352) (← links)
- Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding (Q34737407) (← links)
- LETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 Genotyping System v2.0 in Central Africa (Q35157767) (← links)
- Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project (Q36186007) (← links)
- Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children (Q36379413) (← links)
- Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting (Q36647012) (← links)
- Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents (Q36941659) (← links)
- High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-section (Q37696892) (← links)
- TB and HIV in the Central African region: current knowledge and knowledge gaps (Q38169113) (← links)
- Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review (Q38208721) (← links)
- Tackling virological failure in HIV-infected children living in Africa (Q38552894) (← links)
- Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients (Q38703935) (← links)
- HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA. (Q42263579) (← links)
- HIV epidemic out of control in Central African Republic (Q46732956) (← links)
- Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen. (Q55516962) (← links)
- High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children (Q62488954) (← links)
- Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon (Q64082080) (← links)
- High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO. (Q64893267) (← links)
- Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study) (Q91659834) (← links)
- Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis (Q91980947) (← links)